Symposia on ‘Facial and Vocal Activity as Transdiagnostic Markers of CNS Illness and Treatment Response’ at the 2021 Society of Biological Psychiatry Annual Meeting April 29 through May 01, 2021

Redenlab’s Chief Science Officer (Prof Adam Vogel) presents at the symposia on Facial and Vocal Markers of CNS function, “Speech is a Sensitive Marker of Neuropsychiatric and Neurodegenerative Conditions (in the Right Context)” at 2021 SOBP Annual Meeting, hosted by Isaac Galatzer-Levy (Clinical Research Lead at Facebook).

Symposium Synopsis Facial emotional activity and patterns of speech have all demonstrated relevance across diverse neuropsychiatric conditions including PTSD, Major Depressive Disorder, and schizophrenia. Increasingly, these markers, reflecting clinical characteristics such as blunted/flattened affect or slowed/quieted speech are understood to reflect underlying central nervous system functioning and thus can be used to index disease severity and response to pharmacological treatments. Panelists will present results of analyses of facial and vocal markers as they relate to diverse areas of CNS illness in diverse disorders including PTSD, MDD, Schizophrenia, and suicide risk. The transdiagnostic relevance of facial and vocal markers will be discussed. Further, the relevance of facial and vocal markers for remote digital assessment will be presented.

Related Post

  • Posted on 4 March, 2023
    Join World BI for its 23rd rebranded edition of the Digital Health Innovation in Clinical Trials, Drug Development and Mobile...
    • Posted on 17 November, 2022
      The 4th Annual Kabuki Syndrome Foundation Research Conference to be held virtually on Friday, November 4, 2022. The Annual Conference...
      • Posted on 21 October, 2022
        Join World BI and Redenlab for the 20th Clinical Trials Innovation Programme, to learn from experts in the drug development...